ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. (Q53389043)
Jump to navigation
Jump to search
scientific article published in March 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. |
scientific article published in March 2002 |
Statements
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. (English)
1 reference
Frank T Kolligs
1 reference
Marvin T Nieman
1 reference
Ira Winer
1 reference
Gang Hu
1 reference
David Van Mater
1 reference
Ying Feng
1 reference
Ian M Smith
1 reference
Rong Wu
1 reference
Yali Zhai
1 reference
Kathleen R Cho
1 reference
Eric R Fearon
1 reference
1 March 2002
1 reference
1 reference
1
1 reference
2
1 reference
145-155
1 reference
Identifiers
1 reference